Harvard Profs Battle Over $1.5B Antitrust Damages Estimate
By Bonnie Eslinger ( June 16, 2023, 11:11 PM EDT) -- A Harvard University professor emeritus testifying in a federal antitrust trial Friday over claims Gilead and Teva illegally delayed generic versions of HIV medications told a California jury that the suit's end-payor classes were overcharged $1.5 billion — provoking Gilead to challenge that amount at cross-examination using opinions from its own Harvard expert....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.